CClinicalTrials.gg
Active, not recruitingNCT07549672Updated Apr 28, 2026

Ozone Oil-based Gel and CHX Gel After Lower Third Molar Removal

An Early Phase 1 interventional study of Ozone Oil-based Gel in Pain and Dry Socket, sponsored by Cairo University. Active, not recruiting at 1 site in Egypt. Open to participants aged 21 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-28.

Sponsored by Cairo University · Early Phase 1, Interventional, and Prevention

Phase
Early Phase 1
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
21 Years to 35 Years
Sex
All
01

Study summary

Overall, 100 patients of both genders were included in the study, with indication of surgical extraction of lower third molar, positioned similarly after being clinically and radiographically checked by X-ray and orthopantomography. Each patient was subjected to both groups in separate sessions: treated with ozone gas and with CHX gel 1%. Data on pain intensity, number of taken analgesics- painkillers, and dry socket were recorded for 48 h and at Day 7

Read the detailed description

Overall, 100 patients of both genders were included in the study, with indication of surgical extraction of lower third molar, positioned similarly after being clinically and radiographically checked by X-ray and orthopantomography. Each patient was subjected to both groups in separate sessions: treated with ozone gas and with CHX gel 1%. Data on pain intensity, number of taken analgesics- painkillers, and dry socket were recorded for 48 h and at Day 7

02

Conditions studied

  • Pain
  • Dry Socket

Browse trials for

Keywords

  • Dry socket
  • Pain
  • Lower third molar
03

Who can participate

Ages eligible
21 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients with third impacted bilateral molars, symmetrically in the same position, position evaluated by radiography.
  • Patients in whom operative extraction of third molars is indicated with the creation of a mucoperiosteal flap.
  • Patients regardless of gender.

Exclusion criteria

Exclusion Criteria:

  • Voluntary exclusion of the patient.
  • lack of cooperation in any of the work phase
04

Study design

Phase
Early Phase 1
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    study group and control group

    study group

    Drug: Ozone Oil-based Gel

Interventions

  • DrugOzone Oil-based Gel

    Overall, 30 patients of both genders were included in the study, with indication of surgical extraction of lower third molar, positioned similarly after being clinically and radiographically checked by X-ray and orthopantomography. Each patient was subjected to both groups in separate sessions: treated with ozone gas and with CHX gel 1%. Data on pain intensity, number of taken analgesics- painkillers, and dry socket were recorded for 48 h and at Day 7

    Also known as: CHX Gel

05

What researchers measure

Primary outcomes

  1. pain severity

    pain scale ( VAS ; visual analogue scale) (1-10)

    Time frame: 7 days

Secondary outcomes

  1. dry socket incidence

    bare socket (binary yes/no)

    Time frame: 15 daays

06

Study locations

1 site
  • ASSOCIATE PROFESSOR cairo university
    Cairo, Cairo Governorate 12515, Egypt
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07549672
Lead sponsor
Cairo University
Responsible party
Nahla Mahmoud Awad (associate professor of oral and maxillofacial surgery, Cairo University) — Principal investigator
First posted
Apr 24, 2026
Start date
Jul 1, 2023
Primary completion
Aug 1, 2026 (estimated)
Completion
Sep 1, 2026 (estimated)
Last update
Apr 28, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion